Bill Texts: US HB3839 | 2023-2024 | 118th Congress

Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Sponsorship: Bipartisan Bill

Status: (Introduced - Dead) 2023-06-09 - Referred to the Subcommittee on Health. [HB3839 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2023-07-03PDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for US Congress HB3839

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for US Congress HB3839 currently on file.

feedback